Hemp-Derived CBG tested for anxiety relief in small study

NCT ID NCT05257044

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether cannabigerol (CBG), a compound from hemp, can improve mood, reduce anxiety, and ease stress. 38 adults who had used cannabis before took CBG or a placebo in a double-blind crossover design. Researchers also tracked side effects like sleepiness and dry mouth. The goal is to understand both the benefits and risks of CBG for mental well-being.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

cannabigerol (CBG)

What this could lead to

If it works, this could point toward a natural compound for easing anxiety and stress without serious side effects.

What could go wrong

This is a very early Phase 1 trial with only 38 people, so results may not apply widely. CBG could also cause sleepiness, dry mouth, or other side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FOCUS: TO EXAMINE ACUTE EFFECTS OF CBG ON ANXIETY, STRESS, AND COGNITION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

anxiety disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Washington State University

    Pullman, Washington, 99164, United States